NCT04989179

Brief Summary

This multi-centre, prospective study aims to obtain a precise estimate of the local incidence of PMPS and identify biopsychosocial risk factors contributing to the development of PMPS. Recognition of the impact of PMPS on function and mood and quality of life in cancer survivors, and identification of risk factors would help physicians institute appropriate pre-operative counselling and preventive measures to reduce the development of PMPS. The investigators aim to follow up on the long-term multi-dimensional effects of PMPS, and continue to develop and validate a risk prediction model for patients at risk of PMPS in the next phase of the study.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
220

participants targeted

Target at P75+ for all trials

Timeline
19mo left

Started Oct 2021

Longer than P75 for all trials

Geographic Reach
1 country

3 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Oct 2021Dec 2027

First Submitted

Initial submission to the registry

July 7, 2021

Completed
28 days until next milestone

First Posted

Study publicly available on registry

August 4, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

October 28, 2021

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

December 26, 2025

Status Verified

September 1, 2025

Enrollment Period

5.1 years

First QC Date

July 7, 2021

Last Update Submit

December 18, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Precise estimate of the local incidence and clinical/functional impact of PMPS

    Hypothesized to result from damage to major peripheral nerves during surgery. The International Association for the Study of Pain (IASP) defines PMPS as persistent pain soon after mastectomy/lumpectomy affecting the anterior thorax, axilla, and/or medial upper arm. The primary outcome will be the local incidence of PMPS at 4 months follow-up after surgery.

    4 months

Secondary Outcomes (2)

  • Identify risk factors of PMPS

    4 months

  • Describe factors likely to prevent or reduce the development of PMPS after breast cancer surgery

    4 months

Eligibility Criteria

Age21 Years - 80 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly female patients will be recruited as breast cancer in male is very rare.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Surgeons at the breast clinic listing patients for surgery will inform patients of the study. The clinical research coordinators will approach the potential study participants referred by the study team members and other attending pain clinicians.

You may qualify if:

  • Age 21-80 years old
  • Provided consent for the study
  • Types of breast surgery included: single or bilateral site mastectomies, with or without axillary clearance, wide excision with axillary clearance, radical mastectomies with or without flap surgery.

You may not qualify if:

  • Age below 21 or above 80 years old
  • Male patients
  • Cognitive impairment/ uncommunicative patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Singapore General hospital

Singapore, Singapore, 169608, Singapore

Location

Changi General Hospital

Singapore, Singapore

Location

KK Women's and Children's Hospital

Singapore, Singapore

Location

Related Publications (2)

  • Larsson IM, Ahm Sorensen J, Bille C. The Post-mastectomy Pain Syndrome-A Systematic Review of the Treatment Modalities. Breast J. 2017 May;23(3):338-343. doi: 10.1111/tbj.12739. Epub 2017 Jan 30.

    PMID: 28133848BACKGROUND
  • Tait RC, Zoberi K, Ferguson M, Levenhagen K, Luebbert RA, Rowland K, Salsich GB, Herndon C. Persistent Post-Mastectomy Pain: Risk Factors and Current Approaches to Treatment. J Pain. 2018 Dec;19(12):1367-1383. doi: 10.1016/j.jpain.2018.06.002. Epub 2018 Jun 30.

Biospecimen

Retention: SAMPLES WITH DNA

Blood sampling

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Diana Chan

    Singapore General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 7, 2021

First Posted

August 4, 2021

Study Start

October 28, 2021

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2027

Last Updated

December 26, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations